Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amrubicin in Relapsed or Refractory Thymic Malignancies
NCT01364727Phase 2Completed
- Sponsor
- Heather Wakelee
- Start
- Jun 2011
- Primary completion
- Jul 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of amrubicin in thymoma, thymic carcinoma (TC), sponsored by Heather Wakelee. Started Jun 2011; status: completed.
02
Drugs
amrubicin
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT01364727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364727.